Clinical Trials Contacts

Clinical leads play a key role in developing clinical trials in specific disease areas, as outlined in the table below. Our clinical leads works closely with the CR-UK Clinical Trials Unit, which will coordinate relevant expertise to translate scientific concepts from bench to bedside, and works with the National Health Service, with industry and with academic departments across the UK and internationally. This could include novel therapeutic concepts or new uses for established treatments. 

For general enquiries to the CRUK Clinical Trials Unit about new trials, email newbusiness@trials.bham.ac.uk or phone +44 (0) 121 414 9247.

For disease-specific trial queries, contact the appropriate clinical leads from the tables below.

CIIC OVERALL CLINICAL TRIAL LEADS
Professor Charlie CraddockHaematological Malignancies
Professor Gary MiddletonSolid Tumours

 

CLINICAL THEME LEADS
HAEMATOLOGICAL MALIGNANCIES
Professor Charlie CraddockDirector, SCT Unit, Queen Elizabeth Hospital Birmingham; Member, NCRI AML Subgroup; Chief Investigator, LLR Therapy Acceleration Programme
Professor Paul MossMember, NCRI Haematological Oncology Clinical Studies Group
LUNG CANCER
Professor Gary MiddletonMember of NCRI Lung Cancer Clinical Studies Group
COLORECTAL CANCER
Professor Dion MortonNCRI Colorectal CancerClinical Studies Group, former Chair of Surgical subgroup; Head of Research Committee, Royal College of Surgeons
HEAD AND NECK CANCER
Professor Hisham MehannaChair, NCRI Head and Neck Cancer Clinical Studies Group
LIVER INFLAMMATION AND CANCER
Professor David AdamsHead, NIHR Birmingham Liver BRU
Dr Ye OoMember, NIHR Birmingham Liver BRU
MELANOMA
Dr Neil StevenDeputy Clinical Director, CRCTU; Head of Early Phase Adult Solid Tumour Trials, CRCTU
BLADDER CANCER
Dr Rik BryanMember, NCRI Bladder Cancer Clinical Studies Group; Chief Investigator of the Bladder Cancer Prognosis Programme (BCPP)